SWOG clinical trial number
CTSU/A021501

Preoperative Extended Chemotherapy vs. Chemotherapy Plus Hypofractionated Radiation Therapy for Borderline Resectable Adenocarcinoma of the Head of the Pancreas

Closed
Phase
Abbreviated Title
Preop Extended Chemo vs. Chemo + Plus Hypofractionated Radiation for Borderline Resectable Adenocarcinoma of the Head of the Pancreas
Status Notes
Effective Monday, May 06, 2019 at 4:30 PM ET, Alliance A021501 will be permanently closed to new patient pre-registration (Step 0) as it has met its accrual goal.

Activated
12/15/2016
Participants
ALLIANCE, ECOG-ACRIN, NRG, SWOG

Research committees

Gastrointestinal Cancer

Treatment

5-Fluorouracil Irinotecan Leucovorin Calcium Oxaliplatin

Publication Information Expand/Collapse

2021

Alliance trial A021501: Preoperative mFOLFIRINOX or mFOLFIRINOX plus hypofractionated radiation therapy for borderline resectable adenocarcinoma of the pancreas

M Katz;Q Shi;J Meyers;J Herman;M Chuong;B Wolpin;S Ahmad;R Marsh;L Schwartz;S Behr;W Frankel;E Collisson;J Leenstra;A Venook;J Meyerhardt;E O'Reilly J Clin Oncol 39, 2021 (suppl 3; abstr 419); ASCO GI Cancers Symposium (January 15-17, 2021, virtual)

Other Clinical Trials

SWOG Clinical Trial Number
CTSU/EA2176
SWOG Clinical Trial Number
CTSU/A021806

A Phase III Trial of Perioperative Versus Adjuvant Chemotherapy for Resectable Pancreatic Cancer

Research Committee(s)
Gastrointestinal Cancer
Activated
07/01/2020
Open